J&J’s Ortho-McNeil Wins Topamax Patent Challenge
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan had received ANDA approval in September.
You may also be interested in...
Johnson & Johnson On Track For Eight NME Filings, Approvals In 2007
Firm plans to submit a follow-on to the recently approved antipsychotic Invega by year-end.
Johnson & Johnson On Track For Eight NME Filings, Approvals In 2007
Firm plans to submit a follow-on to the recently approved antipsychotic Invega by year-end.
Mylan Gets ANDA Approval For Generic Of J&J’s Topamax
Mylan unlikely to launch until 2008 unless successful on patent litigation.